{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:05:19Z","timestamp":1787025919903,"version":"build-2736575974"},"reference-count":94,"publisher":"Deutscher Arzte-Verlag GmbH","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.3238\/arztebl.m2023.0228","type":"journal-article","created":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T06:47:53Z","timestamp":1701845273000},"source":"Crossref","is-referenced-by-count":15,"title":["The function of sleep and the treatment of primary insomnia"],"prefix":"10.3238","author":[{"given":"Wolfgang","family":"Freund","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"11437","published-online":{"date-parts":[[2023,12,15]]},"reference":[{"key":"10.3238\/arztebl.m2023.0228_ref1","doi-asserted-by":"crossref","unstructured":"Schmickler JM, Blaschke S, Robbins R, Mess F: Determinants of sleep quality: a cross-sectional study in university students. Int J Environ Res Public Health 2023; 20: 2019.","DOI":"10.3390\/ijerph20032019"},{"key":"10.3238\/arztebl.m2023.0228_ref2","doi-asserted-by":"crossref","unstructured":"Riemann D, Benz F, Dressle RJ, et al.: Insomnia disorder: state of the science and challenges for the future. J Sleep Res 2022; 31: e13604.","DOI":"10.1111\/jsr.13604"},{"key":"10.3238\/arztebl.m2023.0228_ref3","doi-asserted-by":"crossref","unstructured":"Riemann D, Baum E, Cohrs S, et al.: S3-Leitlinie Nicht erholsamer Schlaf\/Schlafst\u00f6rungen. Somnologie 2017; 21: 2–44.","DOI":"10.1007\/s11818-016-0097-x"},{"key":"10.3238\/arztebl.m2023.0228_ref4","doi-asserted-by":"crossref","unstructured":"Ludwig WD, Seifert R, M\u00fchlbauer B: Arzneiverordnungsreport 2022. Springer 2022.","DOI":"10.1007\/978-3-662-66303-5"},{"key":"10.3238\/arztebl.m2023.0228_ref5","unstructured":"AOK: Pers\u00f6nliche Kommunikation und Krankenkassendaten Auswertung zu Schlafmitteln und Schlafst\u00f6rung. In: Freund W (eds.): Stuttgart: Allgemeine Ortskrankenkasse 2022."},{"key":"10.3238\/arztebl.m2023.0228_ref6","doi-asserted-by":"crossref","unstructured":"Morin CM, B\u00e9langer L, LeBlanc M, et al.: The natural history of insomnia: a population-based 3-year longitudinal study. Arch Intern Med 2009; 169: 447–53.","DOI":"10.1001\/archinternmed.2008.610"},{"key":"10.3238\/arztebl.m2023.0228_ref7","doi-asserted-by":"crossref","unstructured":"Grimmsmann T, Kostev K, Himmel W: The role of private prescriptions in benzodiazepine and Z-drug use—a secondary analysis of office-based prescription data. Dtsch Arztebl Int 2022; 119: 380–1.","DOI":"10.3238\/arztebl.m2022.0151"},{"key":"10.3238\/arztebl.m2023.0228_ref8","doi-asserted-by":"crossref","unstructured":"Qaseem A, Kansagara D, Forciea MA, Cooke M, Denberg TD, Clinical Guidelines Committee of the American College of Physicians: Management of chronic insomnia disorder in adults: a clinical practice guideline from the American College of Physicians. Ann Intern Med 2016; 165: 125–33.","DOI":"10.7326\/M15-2175"},{"key":"10.3238\/arztebl.m2023.0228_ref9","doi-asserted-by":"crossref","unstructured":"Riemann D, Baglioni C, Bassetti C, et al.: European guideline for the diagnosis and treatment of insomnia. J Sleep Res 2017; 26: 675–700.","DOI":"10.1111\/jsr.12594"},{"key":"10.3238\/arztebl.m2023.0228_ref10","doi-asserted-by":"crossref","unstructured":"Porkka-Heiskanen T, Zitting KM, Wigren HK: Sleep, its regulation and possible mechanisms of sleep disturbances. Acta physiologica 2013; 208: 311–28.","DOI":"10.1111\/apha.12134"},{"key":"10.3238\/arztebl.m2023.0228_ref11","doi-asserted-by":"crossref","unstructured":"White B, Snyder HS, Patel MVB: Evaluation of medications used for hospitalized patients with sleep disturbances: a frequency analysis and literature review J Pharm Pract 2023; 36: 126–38.","DOI":"10.1177\/08971900211017857"},{"key":"10.3238\/arztebl.m2023.0228_ref12","doi-asserted-by":"crossref","unstructured":"Rodenbeck A: Manual der American Academy of Sleep Medicine. Somnologie 2013; 17: 122–30.","DOI":"10.1007\/s11818-013-0611-3"},{"key":"10.3238\/arztebl.m2023.0228_ref13","doi-asserted-by":"crossref","unstructured":"Weiss JT, Donlea JM: Roles for sleep in neural and behavioral plasticity: reviewing variation in the consequences of sleep loss. Front Behav Neurosci 2021; 15: 777799.","DOI":"10.3389\/fnbeh.2021.777799"},{"key":"10.3238\/arztebl.m2023.0228_ref14","doi-asserted-by":"crossref","unstructured":"Stich FM, Huwiler S, D‘Hulst G, Lustenberger C: The potential role of sleep in promoting a healthy body composition: underlying mechanisms determining muscle, fat, and bone mass and their association with sleep. Neuroendocrinology 2022; 112: 673–701.","DOI":"10.1159\/000518691"},{"key":"10.3238\/arztebl.m2023.0228_ref15","doi-asserted-by":"crossref","unstructured":"Altena E, Micoulaud-Franchi JA, Geoffroy PA, Sanz-Arigita E, Bioulac S, Philip P: The bidirectional relation between emotional reactivity and sleep: from disruption to recovery. Behav Neurosci 2016; 130: 336–50.","DOI":"10.1037\/bne0000128"},{"key":"10.3238\/arztebl.m2023.0228_ref16","doi-asserted-by":"crossref","unstructured":"Albrecht U, Ripperger JA: Circadian clocks and sleep: impact of rhythmic metabolism and waste clearance on the brain. Trends Neurosci 2018; 41: 677–88.","DOI":"10.1016\/j.tins.2018.07.007"},{"key":"10.3238\/arztebl.m2023.0228_ref17","doi-asserted-by":"crossref","unstructured":"Gordleeva S, Kanakov O, Ivanchenko M, Zaikin A, Franceschi C: Brain aging and garbage cleaning: modelling the role of sleep, glymphatic system, and microglia senescence in the propagation of inflammaging. Semin Immunopathol 2020; 42: 647–65.","DOI":"10.1007\/s00281-020-00816-x"},{"key":"10.3238\/arztebl.m2023.0228_ref18","doi-asserted-by":"crossref","unstructured":"Miyanishi K, Sato A, Kihara N, Utsunomiya R, Tanaka J: Synaptic elimination by microglia and disturbed higher brain functions. Neurochem Int 2021; 142: 104901.","DOI":"10.1016\/j.neuint.2020.104901"},{"key":"10.3238\/arztebl.m2023.0228_ref19","doi-asserted-by":"crossref","unstructured":"Iliff JJ, Wang M, Liao Y, et al.: A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid β. Sci Transl Med 2012; 4: 147ra11.","DOI":"10.1126\/scitranslmed.3003748"},{"key":"10.3238\/arztebl.m2023.0228_ref20","doi-asserted-by":"crossref","unstructured":"Rasmussen MK, Mestre H, Nedergaard M: Fluid transport in the brain. Physiol Rev 2022; 102: 1025–151.","DOI":"10.1152\/physrev.00031.2020"},{"key":"10.3238\/arztebl.m2023.0228_ref21","doi-asserted-by":"crossref","unstructured":"Matsumoto S, Tsunematsu T: Association between sleep, alzheimer‘s, and parkinson‘s disease. Biology (Basel) 2021; 10: 1127.","DOI":"10.3390\/biology10111127"},{"key":"10.3238\/arztebl.m2023.0228_ref22","doi-asserted-by":"crossref","unstructured":"Hassinger AB, Bletnisky N, Dudekula R, El-Solh AA: Selecting a pharmacotherapy regimen for patients with chronic insomnia. Expert Opin Pharmacother 2020; 21: 1035–43.","DOI":"10.1080\/14656566.2020.1743265"},{"key":"10.3238\/arztebl.m2023.0228_ref23","doi-asserted-by":"crossref","unstructured":"Altena E, Ellis J, Camart N, Guichard K, Bastien C: Mechanisms of cognitive behavioural therapy for insomnia. J Sleep Res 2023: e13860.","DOI":"10.1111\/jsr.13860"},{"key":"10.3238\/arztebl.m2023.0228_ref24","doi-asserted-by":"crossref","unstructured":"Savin KL, Clark TL, Perez-Ramirez P, Allen TS, Tristao Parra M, Gallo LC: The effect of cognitive behavioral therapy for insomnia (CBT-I) on cardiometabolic health biomarkers: a systematic review of randomized controlled trials. Behav Sleep Med 2023; 21: 671–94.","DOI":"10.1080\/15402002.2022.2154213"},{"key":"10.3238\/arztebl.m2023.0228_ref25","doi-asserted-by":"crossref","unstructured":"Espie CA, Emsley R, Kyle SD, et al.: Effect of digital cognitive behavioral therapy for insomnia on health, psychological well-being, and sleep-related quality of life: a randomized clinical trial. JAMA Psychiatry 2019; 76: 21–30.","DOI":"10.1001\/jamapsychiatry.2018.2745"},{"key":"10.3238\/arztebl.m2023.0228_ref26","doi-asserted-by":"crossref","unstructured":"Sys J, Van Cleynenbreugel S, Deschodt M, Van der Linden L, Tournoy J: Efficacy and safety of non-benzodiazepine and non-Z-drug hypnotic medication for insomnia in older people: a systematic literature review. Eur J Clin Pharmacol 2020; 76: 363–81.","DOI":"10.1007\/s00228-019-02812-z"},{"key":"10.3238\/arztebl.m2023.0228_ref27","doi-asserted-by":"crossref","unstructured":"Nafti M, Sirois C, Kroger E, Carmichael PH, Laurin D: Is benzodiazepine use associated with the risk of dementia and cognitive impairment-not dementia in older persons? The Canadian Study of Health and Aging. Ann Pharmacother 2020; 54: 219–25.","DOI":"10.1177\/1060028019882037"},{"key":"10.3238\/arztebl.m2023.0228_ref28","doi-asserted-by":"crossref","unstructured":"Scharner V, Hasieber L, Sonnichsen A, Mann E: Efficacy and safety of Z-substances in the management of insomnia in older adults: a systematic review for the development of recommendations to reduce potentially inappropriate prescribing. BMC Geriatr 2022; 22: 87.","DOI":"10.1186\/s12877-022-02757-6"},{"key":"10.3238\/arztebl.m2023.0228_ref29","doi-asserted-by":"crossref","unstructured":"De Crescenzo F, D‘Alo GL, Ostinelli EG, et al.: Comparative effects of pharmacological interventions for the acute and long-term management of insomnia disorder in adults: a systematic review and network meta-analysis. Lancet 2022; 400: 170–84.","DOI":"10.1016\/S0140-6736(22)00878-9"},{"key":"10.3238\/arztebl.m2023.0228_ref30","doi-asserted-by":"crossref","unstructured":"Barkopoulos P, Cho JH: Hypnotic medications as an adjunct treatment to cognitive behavioral therapy for insomnia. Sleep Med Clin 2023; 18: 95–111.","DOI":"10.1016\/j.jsmc.2022.10.004"},{"key":"10.3238\/arztebl.m2023.0228_ref31","doi-asserted-by":"crossref","unstructured":"Thomas SJ, Sakhuja S, Colantonio LD, et al.: Insomnia diagnosis, prescribed hypnotic medication use, and risk for serious fall injuries in the reasons for geographic and racial differences in stroke (REGARDS) Study. Sleep 2022; 45: zsac063.","DOI":"10.1093\/sleep\/zsac063"},{"key":"10.3238\/arztebl.m2023.0228_ref32","doi-asserted-by":"crossref","unstructured":"Cherian KE, Kapoor N, Paul TV: Disrupted sleep architecture is associated with incident bone loss in Indian postmenopausal women: a prospective study. J Bone Miner Res 2022; 37: 1956–62.","DOI":"10.1002\/jbmr.4662"},{"key":"10.3238\/arztebl.m2023.0228_ref33","doi-asserted-by":"crossref","unstructured":"Lim AS, Kowgier M, Yu L, Buchman AS, Bennett DA: Sleep fragmentation and the risk of incident alzheimer‘s disease and cognitive decline in older persons. Sleep 2013; 36: 1027–32.","DOI":"10.5665\/sleep.2802"},{"key":"10.3238\/arztebl.m2023.0228_ref34","doi-asserted-by":"crossref","unstructured":"Zhao B, Meng Y, Jin X, et al.: Association of objective and self-reported sleep duration with all-cause and cardiovascular disease mortality: a community-based study. J Am Heart Assoc 2023; 12: e027832.","DOI":"10.1161\/JAHA.122.027832"},{"key":"10.3238\/arztebl.m2023.0228_ref35","doi-asserted-by":"crossref","unstructured":"Gimenez S, Clos S, Romero S, Grasa E, Morte A, Barbanoj MJ: Effects of olanzapine, risperidone and haloperidol on sleep after a single oral morning dose in healthy volunteers. Psychopharmacology (Berl) 2007; 190: 507–16.","DOI":"10.1007\/s00213-006-0633-7"},{"key":"10.3238\/arztebl.m2023.0228_ref36","doi-asserted-by":"crossref","unstructured":"Thakkar MM: Histamine in the regulation of wakefulness. Sleep Med Rev 2011; 15: 65–74.","DOI":"10.1016\/j.smrv.2010.06.004"},{"key":"10.3238\/arztebl.m2023.0228_ref37","doi-asserted-by":"crossref","unstructured":"Mitchell LJ, Bisdounis L, Ballesio A, Omlin X, Kyle SD: The impact of cognitive behavioural therapy for insomnia on objective sleep parameters: a meta-analysis and systematic review. Sleep Med Rev 2019; 47: 90–102.","DOI":"10.1016\/j.smrv.2019.06.002"},{"key":"10.3238\/arztebl.m2023.0228_ref38","doi-asserted-by":"crossref","unstructured":"Simon L, Steinmetz L, Feige B, Benz F, Spiegelhalder K, Baumeister H: Comparative efficacy of onsite, digital, and other settings for cognitive behavioral therapy for insomnia: a systematic review and network meta-analysis. Sci Rep 2023; 13: 1929.","DOI":"10.1038\/s41598-023-28853-0"},{"key":"10.3238\/arztebl.m2023.0228_ref39","doi-asserted-by":"crossref","unstructured":"Baglioni C, Altena E, Bjorvatn B, et al.: The European Academy for Cognitive Behavioural Therapy for Insomnia: an initiative of the European insomnia network to promote implementation and dissemination of treatment. J Sleep Res 2020; 29: e12967.","DOI":"10.1111\/jsr.12967"},{"key":"10.3238\/arztebl.m2023.0228_ref40","doi-asserted-by":"crossref","unstructured":"Dubovsky SL, Marshall D: Benzodiazepines remain important therapeutic options in psychiatric practice. Psychother Psychosom 2022; 91: 1–28.","DOI":"10.1159\/000524400"},{"key":"10.3238\/arztebl.m2023.0228_ref41","doi-asserted-by":"crossref","unstructured":"Bioulac S, Micoulaud-Franchi JA, Arnaud M, et al.: Risk of motor vehicle accidents related to sleepiness at the wheel: a systematic review and meta-analysis. Sleep 2018; 41.","DOI":"10.1093\/sleep\/zsy075"},{"key":"10.3238\/arztebl.m2023.0228_ref42","unstructured":"Lyons B: Medical manslaughter. Ir Med J 2013; 106: 26–7."},{"key":"10.3238\/arztebl.m2023.0228_ref43","doi-asserted-by":"crossref","unstructured":"Smith AJ, Verkman AS: The „glymphatic“ mechanism for solute clearance in alzheimer‘s disease: game changer or unproven speculation? FASEB J 2018; 32: 543–51.","DOI":"10.1096\/fj.201700999"},{"key":"10.3238\/arztebl.m2023.0228_ref44","doi-asserted-by":"crossref","unstructured":"Lazarus M, Oishi Y, Bjorness TE, Greene RW: Gating and the need for sleep: dissociable effects of adenosine A1 and A2A receptors. Front Neurosci 2019; 13: 740.","DOI":"10.3389\/fnins.2019.00740"},{"key":"10.3238\/arztebl.m2023.0228_ref45","unstructured":"Rechtschaffen A, Kales A: A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects. In: U.S. Dept. of Health E, and Welfare (eds.): Washington DC: US Government Printing Office 1968."},{"key":"10.3238\/arztebl.m2023.0228_ref46","doi-asserted-by":"crossref","unstructured":"Choudhury ME, Miyanishi K, Takeda H, Tanaka J: Microglia and the aging brain: are geriatric microglia linked to poor sleep quality? Int J Mol Sci 2021; 22: 7824.","DOI":"10.3390\/ijms22157824"},{"key":"10.3238\/arztebl.m2023.0228_ref47","doi-asserted-by":"crossref","unstructured":"Christensen J, Li C, Mychasiuk R: Choroid plexus function in neurological homeostasis and disorders: the awakening of the circadian clocks and orexins. J Cereb Blood Flow Metab 2022; 42: 1163–75.","DOI":"10.1177\/0271678X221082786"},{"key":"10.3238\/arztebl.m2023.0228_ref48","doi-asserted-by":"crossref","unstructured":"Hatori M, Gronfier C, Van Gelder RN, et al.: Global rise of potential health hazards caused by blue light-induced circadian disruption in modern aging societies. NPJ Aging Mech Dis 2017; 3: 9.","DOI":"10.1038\/s41514-017-0010-2"},{"key":"10.3238\/arztebl.m2023.0228_ref49","doi-asserted-by":"crossref","unstructured":"Musiek ES, Holtzman DM: Mechanisms linking circadian clocks, sleep, and neurodegeneration. Science 2016; 354: 1004–8.","DOI":"10.1126\/science.aah4968"},{"key":"10.3238\/arztebl.m2023.0228_ref50","doi-asserted-by":"crossref","unstructured":"Alrousan G, Hassan A, Pillai AA, Atrooz F, Salim S: Early life sleep deprivation and brain development: insights from human and animal studies. Front Neurosci 2022; 16: 833786.","DOI":"10.3389\/fnins.2022.833786"},{"key":"10.3238\/arztebl.m2023.0228_ref51","doi-asserted-by":"crossref","unstructured":"Palagini L, Geoffroy PA, Balestrieri M, et al.: Current models of insomnia disorder: a theoretical review on the potential role of the orexinergic pathway with implications for insomnia treatment. J Sleep Res 2023: e13825.","DOI":"10.1111\/jsr.13825"},{"key":"10.3238\/arztebl.m2023.0228_ref52","doi-asserted-by":"crossref","unstructured":"Naganawa S, Taoka T: The glymphatic system: a review of the challenges in visualizing its structure and function with MR imaging. Magn Reson Med Sci 2022; 21: 182–94.","DOI":"10.2463\/mrms.rev.2020-0122"},{"key":"10.3238\/arztebl.m2023.0228_ref53","doi-asserted-by":"crossref","unstructured":"Benveniste H, Liu X, Koundal S, Sanggaard S, Lee H, Wardlaw J: The glymphatic system and waste clearance with brain aging: a review. Gerontology 2019; 65: 106–19.","DOI":"10.1159\/000490349"},{"key":"10.3238\/arztebl.m2023.0228_ref54","doi-asserted-by":"crossref","unstructured":"Benveniste H, Heerdt PM, Fontes M, Rothman DL, Volkow ND: Glymphatic system function in relation to anesthesia and sleep states. Anesth Analg 2019; 128: 747–58.","DOI":"10.1213\/ANE.0000000000004069"},{"key":"10.3238\/arztebl.m2023.0228_ref55","doi-asserted-by":"crossref","unstructured":"Meyerhoff J, Chakraborty N, Hammamieh R: Glymphatics: a transformative development in medical neuroscience relevant to injuries in military central nervous system. Mil Med 2022; 187: e1086-e1090.","DOI":"10.1093\/milmed\/usab344"},{"key":"10.3238\/arztebl.m2023.0228_ref56","doi-asserted-by":"crossref","unstructured":"Ferini-Strambi L, Galbiati A, Casoni F, Salsone M: Therapy for insomnia and circadian rhythm disorder in alzheimer disease. Curr Treat Options Neurol 2020; 22: 4.","DOI":"10.1007\/s11940-020-0612-z"},{"key":"10.3238\/arztebl.m2023.0228_ref57","doi-asserted-by":"crossref","unstructured":"Scullin MK, Bliwise DL: Sleep, cognition, and normal aging: integrating a half century of multidisciplinary research. Perspect Psychol Sci 2015; 10: 97–137.","DOI":"10.1177\/1745691614556680"},{"key":"10.3238\/arztebl.m2023.0228_ref58","doi-asserted-by":"crossref","unstructured":"Dressle RJ, Riemann D, Spiegelhalder K, Frase L, Perlis ML, Feige B: On the relationship between EEG spectral analysis and pre-sleep cognitive arousal in insomnia disorder: towards an integrated model of cognitive and cortical arousal. J Sleep Res 2023: e13861.","DOI":"10.1111\/jsr.13861"},{"key":"10.3238\/arztebl.m2023.0228_ref59","doi-asserted-by":"crossref","unstructured":"Trockel M, Karlin BE, Taylor CB, Manber R: Cognitive behavioral therapy for insomnia with veterans: evaluation of effectiveness and correlates of treatment outcomes. Behav Res Ther 2014; 53: 41–6.","DOI":"10.1016\/j.brat.2013.11.006"},{"key":"10.3238\/arztebl.m2023.0228_ref60","doi-asserted-by":"crossref","unstructured":"Chan WS, McCrae CS, Ng AS: Is cognitive behavioral therapy for insomnia effective for improving sleep duration in individuals with insomnia? A meta-analysis of randomized controlled trials. Ann Behav Med 2023; 57: 428–41.","DOI":"10.1093\/abm\/kaac061"},{"key":"10.3238\/arztebl.m2023.0228_ref61","doi-asserted-by":"crossref","unstructured":"Chung KF, Lee CT, Yeung WF, Chan MS, Chung EW, Lin WL: Sleep hygiene education as a treatment of insomnia: a systematic review and meta-analysis. Fam Pract 2018; 35: 365–75.","DOI":"10.1093\/fampra\/cmx122"},{"key":"10.3238\/arztebl.m2023.0228_ref62","doi-asserted-by":"crossref","unstructured":"Rhyne DN, Anderson SL: Suvorexant in insomnia: efficacy, safety and place in therapy. Ther Adv Drug Saf 2015; 6: 189–95.","DOI":"10.1177\/2042098615595359"},{"key":"10.3238\/arztebl.m2023.0228_ref63","doi-asserted-by":"crossref","unstructured":"Patel KV, Aspesi AV, Evoy KE: Suvorexant: a dual orexin receptor antagonist for the treatment of sleep onset and sleep maintenance insomnia. Ann Pharmacother 2015; 49: 477–83.","DOI":"10.1177\/1060028015570467"},{"key":"10.3238\/arztebl.m2023.0228_ref64","doi-asserted-by":"crossref","unstructured":"Sun H, Kennedy WP, Wilbraham D, et al.: Effects of suvorexant, an orexin receptor antagonist, on sleep parameters as measured by polysomnography in healthy men. Sleep 2013; 36: 259–67.","DOI":"10.5665\/sleep.2386"},{"key":"10.3238\/arztebl.m2023.0228_ref65","doi-asserted-by":"crossref","unstructured":"Picton JD, Marino AB, Nealy KL: Benzodiazepine use and cognitive decline in the elderly Am J Health Syst Pharm 2018; 75: e6–e12.","DOI":"10.2146\/ajhp160381"},{"key":"10.3238\/arztebl.m2023.0228_ref66","doi-asserted-by":"crossref","unstructured":"Kunz D: Rethinking the use of hypnotics for treatment of insomnia in the elderly. Expert Opin Pharmacother 2021; 22: 953–7.","DOI":"10.1080\/14656566.2021.1900116"},{"key":"10.3238\/arztebl.m2023.0228_ref67","doi-asserted-by":"crossref","unstructured":"Besag FMC, Vasey MJ, Lao KSJ, Wong ICK: Adverse events associated with melatonin for the treatment of primary or secondary sleep disorders: a systematic review. CNS Drugs 2019; 33: 1167–86.","DOI":"10.1007\/s40263-019-00680-w"},{"key":"10.3238\/arztebl.m2023.0228_ref68","doi-asserted-by":"crossref","unstructured":"Wade AG, Ford I, Crawford G, et al.: Efficacy of prolonged release melatonin in insomnia patients aged 55–80 years: quality of sleep and next-day alertness outcomes. Curr Med Res Opin 2007; 23: 2597–605.","DOI":"10.1185\/030079907X233098"},{"key":"10.3238\/arztebl.m2023.0228_ref69","doi-asserted-by":"crossref","unstructured":"Carr CN, Lopchuk S, Beckman ME, Baugh TB: Evaluation of the use of low-dose quetiapine and the risk of metabolic consequences: a retrospective review. Ment Health Clin 2016; 6: 308–13.","DOI":"10.9740\/mhc.2016.11.308"},{"key":"10.3238\/arztebl.m2023.0228_ref70","doi-asserted-by":"crossref","unstructured":"Muehlan C, Roch C, Vaillant C, Dingemanse J: The orexin story and orexin receptor antagonists for the treatment of insomnia. J Sleep Res 2023: e13902.","DOI":"10.1111\/jsr.13902"},{"key":"10.3238\/arztebl.m2023.0228_ref71","doi-asserted-by":"crossref","unstructured":"Li Y, Wang S, Pan C, et al.: Comparison of NREM sleep and intravenous sedation through local information processing and whole brain network to explore the mechanism of general anesthesia. PloS one 2018; 13: e0192358.","DOI":"10.1371\/journal.pone.0192358"},{"key":"10.3238\/arztebl.m2023.0228_ref72","unstructured":"Tegenthoff M: Beschleunigungstrauma der HWS. https:\/\/register.awmf.org\/assets\/guidelines\/030-095l_S1_Beschleunigungstrauma-Halswirbelsaeule_2021-04.pdf (last accessed on 23 January 2023)."},{"key":"10.3238\/arztebl.m2023.0228_ref73","doi-asserted-by":"crossref","unstructured":"Miller CB, Valenti L, Harrison CM, et al.: Time trends in the family physician management of insomnia: the Australian experience (2000–2015). J Clin Sleep Med 2017; 13: 785–90.","DOI":"10.5664\/jcsm.6616"},{"key":"10.3238\/arztebl.m2023.0228_ref74","doi-asserted-by":"crossref","unstructured":"Koffel E, Bramoweth AD, Ulmer CS: Increasing access to and utilization of cognitive behavioral therapy for insomnia (CBT-I): a narrative review. J Gen Intern Med 2018; 33: 955–62.","DOI":"10.1007\/s11606-018-4390-1"},{"key":"10.3238\/arztebl.m2023.0228_ref75","doi-asserted-by":"crossref","unstructured":"Mattos MK, Chang A, Pitcher K, Whitt C, Ritterband LM, Quigg MS: A review of insomnia treatments for patients with mild cognitive impairment. Aging Dis 2021; 12: 1036–42.","DOI":"10.14336\/AD.2021.0423"},{"key":"10.3238\/arztebl.m2023.0228_ref76","unstructured":"Hirsch R: The opioid epidemic: it‘s time to place blame where it belongs. Mo Med 2017; 114: 82–90."},{"key":"10.3238\/arztebl.m2023.0228_ref77","doi-asserted-by":"crossref","unstructured":"Borchert JS, Wang B, Ramzanali M, Stein AB, Malaiyandi LM, Dineley KE: Adverse events due to insomnia drugs reported in a regulatory database and online patient reviews: comparative study. J Med Internet Res 2019; 21: e13371.","DOI":"10.2196\/13371"},{"key":"10.3238\/arztebl.m2023.0228_ref78","doi-asserted-by":"crossref","unstructured":"Krystal AD, Prather AA, Ashbrook LH: The assessment and management of insomnia: an update. World Psychiatry 2019; 18: 337–52.","DOI":"10.1002\/wps.20674"},{"key":"10.3238\/arztebl.m2023.0228_ref79","doi-asserted-by":"crossref","unstructured":"Yamada RG, Ueda HR: Molecular mechanisms of REM sleep. Front Neurosci 2019; 13: 1402.","DOI":"10.3389\/fnins.2019.01402"},{"key":"10.3238\/arztebl.m2023.0228_ref80","doi-asserted-by":"crossref","unstructured":"Madari S, Golebiowski R, Mansukhani MP, Kolla BP: Pharmacological management of insomnia. Neurotherapeutics 2021; 18: 44–52.","DOI":"10.1007\/s13311-021-01010-z"},{"key":"10.3238\/arztebl.m2023.0228_ref81","doi-asserted-by":"crossref","unstructured":"Bailey GA, Hubbard EK, Fasano A, et al.: Sleep disturbance in movement disorders: insights, treatments and challenges. J Neurol Neurosurg Psychiatry 2021; 92: 723–36.","DOI":"10.1136\/jnnp-2020-325546"},{"key":"10.3238\/arztebl.m2023.0228_ref82","doi-asserted-by":"crossref","unstructured":"Lee DW, Lee J, Kim HR, Kang MY: Health-related productivity loss according to health conditions among workers in South Korea. Int J Environ Res Public Health 2021; 18: 7589.","DOI":"10.3390\/ijerph18147589"},{"key":"10.3238\/arztebl.m2023.0228_ref83","doi-asserted-by":"crossref","unstructured":"Nedeltcheva AV, Kilkus JM, Imperial J, Schoeller DA, Penev PD: Insufficient sleep undermines dietary efforts to reduce adiposity. Ann Intern Med 2010; 153: 435–41.","DOI":"10.7326\/0003-4819-153-7-201010050-00006"},{"key":"10.3238\/arztebl.m2023.0228_ref84","doi-asserted-by":"crossref","unstructured":"Pariente A, Dartigues JF, Benichou J, Letenneur L, Moore N, Fourrier-Reglat A: Benzodiazepines and injurious falls in community dwelling elders. Drugs Aging 2008; 25: 61–70.","DOI":"10.2165\/00002512-200825010-00007"},{"key":"10.3238\/arztebl.m2023.0228_ref85","doi-asserted-by":"crossref","unstructured":"Xiuyun W, Jiating L, Minjun X, Weidong L, Qian W, Lizhen L: Network mendelian randomization study: exploring the causal pathway from insomnia to type 2 diabetes. BMJ Open Diabetes Res Care 2022; 10: e002510.","DOI":"10.1136\/bmjdrc-2021-002510"},{"key":"10.3238\/arztebl.m2023.0228_ref86","doi-asserted-by":"crossref","unstructured":"AlDawsari A, Bushell TJ, Abutheraa N, Sakata S, Al Hussain S, Kurdi A: Use of sedative-hypnotic medications and risk of dementia: a systematic review and meta-analysis. Br J Clin Pharmacol 2022; 88: 1567–89.","DOI":"10.1111\/bcp.15113"},{"key":"10.3238\/arztebl.m2023.0228_ref87","doi-asserted-by":"crossref","unstructured":"Parsaik AK, Mascarenhas SS, Khosh-Chashm D, et al.: Mortality associated with anxiolytic and hypnotic drugs—a systematic review and meta-analysis. Aust N Z J Psychiatry 2016; 50: 520–33.","DOI":"10.1177\/0004867415616695"},{"key":"10.3238\/arztebl.m2023.0228_ref88","doi-asserted-by":"crossref","unstructured":"Chambe J, Reynaud E, Maruani J, Fraih E, Geoffroy PA, Bourgin P: Light therapy in insomnia disorder: a systematic review and meta-analysis. J Sleep Res 2023: e13895.","DOI":"10.1111\/jsr.13895"},{"key":"10.3238\/arztebl.m2023.0228_ref89","doi-asserted-by":"crossref","unstructured":"Hertenstein E, Trinca E, Wunderlin M, et al.: Cognitive behavioral therapy for insomnia in patients with mental disorders and comorbid insomnia: a systematic review and meta-analysis. Sleep Med Rev 2022; 62: 101597.","DOI":"10.1016\/j.smrv.2022.101597"},{"key":"10.3238\/arztebl.m2023.0228_ref90","doi-asserted-by":"crossref","unstructured":"Huang K, Li S, He R, et al.: Efficacy of cognitive behavioral therapy for insomnia (CBT-I) in older adults with insomnia: a systematic review and meta-analysis. Australas Psychiatry 2022; 30: 592–7.","DOI":"10.1177\/10398562221118516"},{"key":"10.3238\/arztebl.m2023.0228_ref91","doi-asserted-by":"crossref","unstructured":"Lee S, Oh JW, Park KM, Lee S, Lee E: Digital cognitive behavioral therapy for insomnia on depression and anxiety: a systematic review and meta-analysis. NPJ Digit Med 2023; 6: 52.","DOI":"10.1038\/s41746-023-00800-3"},{"key":"10.3238\/arztebl.m2023.0228_ref92","doi-asserted-by":"crossref","unstructured":"Avidan AY, Palmer LA, Doan JF, Baran RW: Insomnia medication use and the probability of an accidental event in an older adult population. Drug Healthc Patient Saf 2010; 2: 225–32.","DOI":"10.2147\/DHPS.S14955"},{"key":"10.3238\/arztebl.m2023.0228_ref93","doi-asserted-by":"crossref","unstructured":"Roch C, Bergamini G, Steiner MA, Clozel M: Nonclinical pharmacology of daridorexant: a new dual orexin receptor antagonist for the treatment of insomnia. Psychopharmacology (Berl) 2021; 238: 2693–708.","DOI":"10.1007\/s00213-021-05954-0"},{"key":"10.3238\/arztebl.m2023.0228_ref94","doi-asserted-by":"crossref","unstructured":"Dauvilliers Y, Zammit G, Fietze I, et al.: Daridorexant, a new dual orexin receptor antagonist to treat insomnia disorder. Ann Neurol 2020; 87: 347–56.","DOI":"10.1002\/ana.25680"}],"container-title":["Deutsches \u00c4rzteblatt international"],"original-title":[],"link":[{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.m2023.0228","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T06:50:28Z","timestamp":1701845428000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.m2023.0228"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,15]]},"references-count":94,"URL":"https:\/\/doi.org\/10.3238\/arztebl.m2023.0228","relation":{},"ISSN":["1866-0452"],"issn-type":[{"value":"1866-0452","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,15]]}}}